HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Candece L Gladson Selected Research

NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)

3/2010A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.
3/2007ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Candece L Gladson Research Topics

Disease

28Neoplasms (Cancer)
11/2018 - 05/2002
12Glioblastoma (Glioblastoma Multiforme)
11/2017 - 03/2003
7Glioma (Gliomas)
01/2010 - 04/2005
7Astrocytoma (Pilocytic Astrocytoma)
03/2007 - 05/2002
5Brain Neoplasms (Brain Tumor)
11/2018 - 08/2005
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2013 - 07/2009
2Fibrosis (Cirrhosis)
05/2013 - 07/2009
1Neoplasm Metastasis (Metastasis)
11/2018
1Breast Neoplasms (Breast Cancer)
11/2018
1Sepsis (Septicemia)
12/2016
1Ependymoma
11/2012
1Idiopathic Pulmonary Fibrosis
05/2010
1Disease Progression
03/2010
1Necrosis
01/2009
1Carcinogenesis
05/2006
1Skin Neoplasms (Skin Cancer)
10/2005
1Rheumatoid Arthritis
08/2005
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2005
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2005
1Inflammation (Inflammations)
11/2003
1Laryngeal Neoplasms (Laryngeal Cancer)
08/2003
1Squamous Cell Carcinoma of Head and Neck
08/2003

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
11/2018 - 09/2002
8Focal Adhesion Protein-Tyrosine KinasesIBA
05/2013 - 05/2002
5IntegrinsIBA
07/2016 - 09/2002
4Phosphotransferases (Kinase)IBA
05/2010 - 10/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 11/2003
3Laminin (Merosin)IBA
11/2012 - 10/2003
3Small Interfering RNA (siRNA)IBA
01/2011 - 10/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2006 - 03/2003
3src-Family KinasesIBA
07/2005 - 05/2002
3VitronectinIBA
05/2004 - 09/2002
2Monoclonal AntibodiesIBA
11/2017 - 09/2002
2CollagenIBA
03/2012 - 10/2003
2Pharmaceutical PreparationsIBA
03/2010 - 08/2005
2NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)IBA
03/2010 - 03/2007
2LigandsIBA
01/2010 - 01/2009
2ThrombospondinsIBA
03/2007 - 04/2005
2Peptides (Polypeptides)IBA
03/2007 - 09/2002
2Cyclin D1IBA
09/2006 - 02/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2006 - 03/2003
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2005 - 10/2003
2CyclinsIBA
02/2005 - 05/2002
2Integrin alpha ChainsIBA
10/2003 - 03/2003
1Messenger RNA (mRNA)IBA
11/2018
1Bevacizumab (Avastin)FDA Link
11/2017
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Selenoprotein PIBA
12/2016
1SeleniumIBA
12/2016
1arginyl-glycyl-aspartic acidIBA
07/2016
1Biomarkers (Surrogate Marker)IBA
07/2014
1Scavenger Receptors (Scavenger Receptor)IBA
07/2014
1FAK-related nonkinaseIBA
05/2013
1laminin alpha 2IBA
11/2012
1Fibronectins (Fibronectin)IBA
03/2012
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
05/2010
1Temozolomide (Temodar)FDA LinkGeneric
03/2010
1Fibroblast Growth Factor 1 (FGF-1)IBA
03/2010
1Endoplasmic Reticulum Chaperone BiPIBA
07/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2009
1Caspase InhibitorsIBA
01/2009
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2009
1Blocking AntibodiesIBA
01/2009
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2006
1dimemorfan (AT 17)IBA
06/2006
1Dihydrotachysterol (AT 10)IBA
06/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2006
1EnzymesIBA
05/2006
1Syndecan-2IBA
05/2006
1LDL Receptors (LDL Receptor)IBA
10/2005
1CarcinogensIBA
10/2005
1Peptide Hydrolases (Proteases)FDA Link
10/2005
1Proteoglycans (Proteoglycan)IBA
10/2005
1Cystine (L-Cystine)IBA
08/2005
1Glutathione (Reduced Glutathione)IBA
08/2005
1AntioxidantsIBA
08/2005
1Glutamic Acid (Glutamate)FDA Link
08/2005
1Sulfasalazine (Azulfidine)FDA LinkGeneric
08/2005
1Integrin alphaVIBA
07/2005
1AngiostatinsIBA
04/2005
1EndostatinsIBA
04/2005
1AgarIBA
02/2005
1p120 GTPase Activating ProteinIBA
05/2004
1SuspensionsIBA
05/2004
1Oncostatin MIBA
11/2003
1CytokinesIBA
11/2003
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2003
1Integrin alphaVbeta3IBA
10/2003
1integrin alphaVbeta5IBA
10/2003
1Platelet-Derived Growth FactorIBA
10/2003
1Metalloproteases (Metalloproteinases)IBA
08/2003
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2003
1ErbB Receptors (EGF Receptor)IBA
03/2003
1Cell Surface ReceptorsIBA
03/2003

Therapy/Procedure

8Therapeutics
11/2018 - 04/2005
2Euthanasia (Mercy Killing)
03/2007 - 06/2006
1Precision Medicine
11/2018
1Radiotherapy
03/2010
1Intraperitoneal Injections
08/2005